Uranium Royalty Corp. (NASDAQ:UROY) trade information

In the last trading session, 3.2 million shares of the Uranium Royalty Corp. (NASDAQ:UROY) were traded. Most recently the company’s share price was $2.97, and it changed around $0.26 or 9.59% from the last close, which brings the market valuation of the company to $289.08M. UROY currently trades at a discount to its 52-week high of $5.74, offering almost -93.27% off that amount. The share price’s 52-week low was $2.10, which indicates that the current value has risen by an impressive 29.29% since then. We note from Uranium Royalty Corp.’s average daily trading volume that its 10-day average is 0.95 million shares, with the 3-month average coming to 566.71K.

Instantly UROY has showed a green trend with a performance of 9.59% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.06 on Monday, 11/14/22 […]

About the author: StockMan
Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.
Posting Guidelines
Do
  • Do contribute something to the discussion
  • Do post factual information, analysis and your view on company valuations
  • Do disclose if you have an interest in a security
  • Do take our Terms of Use seriously
Do Not
  • Do not make low-content posts, unsubstantiated ramps or untruthful/misleading statements
  • Do not complain about a post unless you have reported it first, and not on the forum.
  • Do not post financial advice
  • Do not advertise or post sponsored content

Get involved!

Get Connected!

Come and join our community. Expand your network and get to know new people!

Comments

No comments yet